Avobis Bio

Avobis Bio is a biotechnology and healthcare startup founded in 2019, dedicated to developing implantable cell therapies for debilitating conditions. The company's investigational portfolio focuses on utilizing mesenchymal stem cells combined with bioabsorbable scaffolds to enhance the cells' effectiveness in stimulating the body to heal. Avobis Bio is a joint venture between Mayo Clinic and W. L. Gore & Associates, leveraging a combination of clinical care, cell biology, materials science, and commercialization of medical products. The company's name, derived from the Latin a vobis, meaning "from you" or "by you," pays tribute to the patients it serves and the power of their own mesenchymal stem cells. With no publicly disclosed headquarter location or last investment details, Avobis Bio stands as an intriguing player in the evolving field of regenerative medicine.